taug_logo_f_improf_179x131Tauriga Sciences, Inc is a diversified biotechnology company that entered the marijuana industry this year. It made its entry by acquiring the medical cannabis manufacturer Honeywood LLC, which became one of Tauriga’s subsidiary companies.

Tauriga was founded in 2001 and has since gone through different businesses and names. Among these are New England Acquisitions, Atlantic Wine Agencies, and Novo Energies Corp. It finally became Tauriga Sciences, Inc in 2013.

Today, Tauriga Sciences, Inc is traded in OTC markets under the symbol TAUG. Its market cap is pegged at USD 14.6 M.

The company takes on the strategy of diversifying its portfolio through the acquisition of licenses, exclusive and non-exclusive rights, as well as entire businesses. Currently, Tauriga’s featured subsidiary companies are Microbial Robotics LLC (previously known as Bacterial Robotics LLC), Pilus Energy LLC, and on the marijuana front, Honeywood LLC.

Microbial Robotics LLC is a firm that bio-engineers certain micro-organisms to ‘program’ them into microscopic robots. Such micro robots are deemed useful in various applications including disease reduction, water cleaning, food cultivation, fuel production, and therapeutics production.

Pilus Energy is a subsidiary of Microbial Robotics and it has also been acquired by Tauriga Sciences. It is also a biotech firm, with a specialty in genetically engineering certain bacteria. The bacteria process wastewater to produce direct current electricity and several useful gases and chemicals.

Lastly, Tauriga’s subsidiary in the medical cannabis space, which it acquired in March 2014, is Honeywood LLC. This subsidiary develops and sells topical cannabis products such as healing creams and skin lotions. It sells these products through online channels under the Doc Greens brand.

At the helm of Tauriga Sciences is Dr. Stella Sung, the company’s CEO, Chairman, COO, and Interim CFO. With her are VP for Strategic Planning Seth M. Shaw, Chief Medical Officer Dr. Lawrence A. May, and Operations Manager Ghalia Lahlou. Other executives include the VP and General Manager of Pilus Energy Ian Harrison, and VP of NuclearBot Development David Schweizer.


Yahoo! Finance: TAUG News

Latest Financial News for TAUG

Tauriga Sciences Inc. Completes the Package Design for Its Cherry Lime Rickey Flavor, Caffeine Infused Tauri-Gum Version

1_25_2021 PR Image Blister Pack Design – Cherry Lime Rickey Tauri-Gum™ Flavor The Tauri-Gum™ Product Line Now Consists of 7 SKUs: Pomegranate (CBD), Blood Orange (CBD), Peach-Lemon (CBG), Pear Bellini (Vitamin C & Zinc), Mint (CBD), Black Currant (CBG), Cherry Lime Rickey (Caffeine) NEW YORK, NY, Jan. 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that it has completed the package design for its Cherry Lime Rickey flavor, Caffeine infused version of Tauri-Gum™. This product is the 7th SKU of the Company’s flagship product line and brand, Tauri-Gum™. The Company expects that inventory, for this Caffeine infused version of Tauri-Gum™, will arrive during this current Quarter (4th Fiscal Quarter of 2021). Each piece of chewing gum is infused with 50mg of Caffeine (roughly equivalent to a 5oz. cup of coffee). In other news, the Company has completed the construction of its Product Showroom – located within its new Corporate Headquarters (Wappingers Falls, New York). The Company continues to experience strong levels of interest in its proprietary products and product lines, from a broad array of prospective Retail, Distribution, Dispensaries, Individual, E-Commerce, Product Development, and Institutional (i.e. Potential Federal Government Contract) customer(s)/partner(s). ABOUT TAURIGA SCIENCES INC. Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Flavor: Pear Bellini). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative. This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts. On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4) The Company is headquartered in Wappingers Falls, New York. In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York. DISCLAIMER -- Forward-Looking Statements This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements. Contact: Tauriga Sciences, Inc. 4 Nancy Court, Suite 4 Wappingers Falls, NY 12590 Chief Executive Officer Mr. Seth M. Shaw Email: sshaw@tauriga.com cell # (917) 796 9926 Company Instagram: @taurigum Personal Instagram: @sethsms47 Twitter: @SethMShaw Corp. Website: www.tauriga.com E-Commerce Website: www.taurigum.com Attachment 1_25_2021 PR Image

Tauriga Sciences, Inc. Signs Major Distribution Agreement with Online Grocer and Wholesaler, Stock Up Express

Stock Up Express (www.stockupexpress.com) Receives More Than 1,000,000 Annual Online Visitors, Consisting of a Diverse Group of Customers NEW YORK, NY, Jan. 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that it has entered into a distribution agreement (the “Agreement”) with Stock Up Express, a division of a leading total services distributor that generates more than $3 Billion in annual sales. Stock Up Express is based in Connecticut and is a leading web-based grocer and wholesaler with over 1,000,000 online visitors annually. The Agreement will be effective February 1, 2021, and shall remain in effect for a period of two (2) years thereafter, with automatic renewal for additional successive one (1) year terms. Under terms of the Agreement, Stock Up Express will market and resell the Company’s flagship brand, Tauri-Gum™, to its large and diverse customer base of wholesalers and retail customers. The revenue sharing ratio established between Tauriga and Stock Up Express has the potential to create significant opportunity for both parties to this Agreement (solid gross margins). Tauri-Gum™ represents the first CBD edibles product/product line to be selected as part of the Stock Up Express network. The two Companies will jointly market Tauri-Gum™ to Stock Up Express’ customer base, with input by Tauriga on the content of such marketing information to attain consistency on message and to maximize sales. The Agreement allows for modification of product offerings, and Tauriga expects to offer additional items over the course of calendar year 2021. Tauriga’s CEO, Seth M. Shaw, expressed, “This agreement is an important achievement for Tauriga. Due to the quality of our flagship Tauri-Gum™ product line, the strong team that we have built, and the improving macro-outlook for our industry, this Agreement became possible. Stock Up Express is an outstanding distribution partner and the Company now has access to a large, previously untapped, market segment, at margins that the Company believes is conducive to long term success. Our long-term goal is for Tauri-Gum™ to become a successful, widely distributed, consumer friendly CBD edibles brand. We have now taken an important step in that direction.” Stock Up Express’ Vice President of E-Commerce, Steven Methvin, commented, “After much consideration and the evaluation of numerous CBD products, our Company has made the decision to enter the CBD edibles space through Tauriga Sciences Inc. and its high-quality products. Stock Up Express will provide an opportunity to present the Tauri-Gum™ brand (and possibly other product offerings to follow) to a large and engaged base of wholesalers and retail customers. Our respective teams work well together and we are all committed to working hard and strategically to build a successful distribution partnership and business model.” Tauriga Sciences, Inc. was represented by the law firm of Rimon P.C. in the preparation of the Agreement. ABOUT TAURIGA SCIENCES, INC. Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Flavor: Pear Bellini). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative. This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT.” On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts. On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4) The Company is headquartered in Wappingers Falls, New York. In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York. ABOUT STOCK UP EXPRESS ONLINE Convenient Warehouse Shopping: We know you need to buy lots of goods with no time to waste. That’s why we created our virtual warehouse. At StockUpExpress, we sell case-size quantities of grocery, personal care, and household items from hundreds of national and regional brands. Since we are all about convenience, items in our cases are the normal shelf-size, not the jumbo club-size packaging offered at the big box stores. Unlike other e-commerce sites, StockUpExpress has the capability to ship mass amounts of product quickly and efficiently. We cover the heavy lifting and logistics, letting your business or event run smoothly all with just the click of a button. Development for Stock Up Express began in 2014. Our parent company, iMarket Technologies, LLC, was also launched in 2014 and is led by a team of executives with deep experience in warehouse operations, consumer packaged goods merchandising, logistics, and online retailing. Please visit our Website at: https://www.stockupexpress.com DISCLAIMER -- Forward-Looking Statements This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward-looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements. Contact: Tauriga Sciences, Inc.4 Nancy Court, Suite 4Wappingers Falls, NY 12590Chief Executive OfficerMr. Seth M. ShawEmail: sshaw@tauriga.comCell # (917) 796 9926Company Instagram: @taurigumPersonal Instagram: @sethsms47Twitter: @SethMShawCorp. Website: www.tauriga.com E-Commerce Website: www.taurigum.com

Tauriga Sciences Inc. Approved to Operate Virtual Exhibitor Booth at PGA Merchandise Show 2021 -- January 26th- 29th 2021

1_21 PR Tauriga Sciences Inc. Exhibitor Booth at 2020 PGA Merchandise Show The Company Will Showcase Its Flagship Brand, Tauri-Gum™, as Well as Its Expanded Product Offerings NEW YORK, NY, Jan. 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that it will operate a Virtual Exhibitor Booth (“Virtual Booth”) at the Professional Golfers’ Association (“PGA”) Merchandise Show 2021, which takes place on January 26th- 29th, 2021. Last year, the Company operated a successful and highly visited Corporate Exhibitor Booth (#4507) at the PGA Merchandise Show 2020 – which took place in Orlando, Florida (January 21st- 24th, 2020). The Company has established many important relationships, throughout the golf industry, as a result of the positive exposure from last year’s Tradeshow. The Company currently sells its Tauri-Gum™ product line to a number of golf pro shops and industry themed stores. Additionally, the Company has received online E-Commerce order(s) from professional golfer(s). Moving forward, the Company plans to further penetrate this large market segment (golf industry), during calendar year 2021 and beyond. In other news, the Company is pleased to confirm that it has received its 5,000thE-Commerce order (on January 19th, 2021). The average order size ($ dollar amount), per individual online E-Commerce transaction, has been steadily increasing over the past months. The Company is confident that its highest margin E-Commerce business segment will continue to experience meaningful levels of growth. Lastly, the Company has officially launched an improved and updated version of its corporate website (www.tauriga.com). This website version also includes the Company’s updated power point presentation (please click on the “Who We Are” tab). ABOUT TAURIGA SCIENCES INC. Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Flavor: Pear Bellini). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative. This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts. On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4) The Company is headquartered in Wappingers Falls, New York. In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York. DISCLAIMER -- Forward-Looking Statements This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements. Contact: Tauriga Sciences, Inc. 4 Nancy Court, Suite 4 Wappingers Falls, NY 12590 Chief Executive Officer Mr. Seth M. Shaw Email: sshaw@tauriga.com cell # (917) 796 9926 Company Instagram: @taurigum Personal Instagram: @sethsms47 Twitter: @SethMShaw Corp. Website: www.tauriga.com E-Commerce Website: www.taurigum.com Attachment 1_21 PR

Tauriga Sciences Inc. to Construct Product Showroom Within its New Corporate Headquarters

NEW YORK, NY, Jan. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that it is constructing a Product Showroom (“Showroom”) inside its new corporate headquarters. The Company has made this decision in anticipation of and in preparation for important future Agreement(s) & Partnership(s). The Company expects to host a broad array of prospective new customers, once this Showroom is functional. These potential new customers include, but are not limited to: Individual Customers, Mom & Pop Stores, Gas Station Convenience Stores, Large Regional & National Retailers, Major Distributors, and College Campus Stores. The Company believes that its Product Showroom will be up and running, on or before February 1, 2021. The Company continues to realize important levels of progress with respect to a number of different corporate initiatives and expects to disclose to shareholders one or more material Agreement(s) or Partnership(s) within the very near term. ABOUT TAURIGA SCIENCES INC. Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Flavor: Pear Bellini). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative. This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts. On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4) The Company is headquartered in Wappingers Falls, New York. In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York. DISCLAIMER -- Forward-Looking Statements This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements. Contact: Tauriga Sciences, Inc. 4 Nancy Court, Suite 4 Wappingers Falls, NY 12590 Chief Executive Officer Mr. Seth M. Shaw Email: sshaw@tauriga.com cell # (917) 796 9926 Company Instagram: @taurigum Personal Instagram: @sethsms47 Twitter: @SethMShaw Corp. Website: www.tauriga.com E-Commerce Website: www.taurigum.com

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

NEW YORK, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that, in compliance with the Florida Business Corporations Act, and its governing corporate documents and rules relating thereto, the Company’s board will take immediate steps to begin increasing the number of members serving on its Board of Directors (“Board”) to seven, with a majority of such resulting Board being “independent” members. Additionally, the Company will promptly begin implementing more stringent and improved corporate governance (“Governance”) protocols and policies. We intend to implement and complete these steps by March 31, 2021 or as soon as practicable. In addition to appointing qualified and experienced new board members, the Company has also committed to focus on diversity in appointing one or more members to our Board. As required under applicable SEC disclosure rules, we will timely report any new board appointments as they occur either via Form 8-K or such other quarterly or annual report, as the case may be. With respect to implementing a more comprehensive set of Governance protocols and policies, the Company plans to establish the following Committee(s): Audit Committee, Compensation Committee, Nomination Committee, and to implement a Code of Conduct policy, and a qualified equity incentive compensation plan, each of which will be included or described in the Company’s SEC filings as and when implemented. We believe that executing on the above-noted items will both strengthen our Company from a governance perspective and an operational one as well, as we will seek board members with appropriate experience and backgrounds that can help us sustain and improve further growth. The Company’s long-term goal is to execute on its business plan and corporate objectives and, ultimately, to up-list to a national stock exchange, such as the NASDAQ Stock Market if and when we are able to meet such listing and maintenance requirements; however, there can be no guarantee that any future up-listing can or will occur. Lastly, the Company expects to appoint a 4thMember to its Board of Directors, within the very near term. This 4thBoard Member, once formally appointed, will serve as an Independent Director. ABOUT TAURIGA SCIENCES INC. Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Flavor: Pear Bellini). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative. This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts. On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4) The Company is headquartered in Wappingers Falls, New York. In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York. DISCLAIMER -- Forward-Looking Statements This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements. Contact: Tauriga Sciences, Inc. 4 Nancy Court, Suite 4 Wappingers Falls, NY 12590 Chief Executive Officer Mr. Seth M. Shaw Email: sshaw@tauriga.com cell # (917) 796 9926 Company Instagram: @taurigum Personal Instagram: @sethsms47 Twitter: @SethMShaw Corp. Website: www.tauriga.com E-Commerce Website: www.taurigum.com